PRR15 methylation profiles in pan-cancer were explored, revealing that PRR15 methylation degrees were markedly reduced in several tumors than in normal tissues, including BRCA, uterine corpus endometrial carcinoma, and prostate adenocarcinoma (Fig. S2g). This evidence concerns the gene PRR15 and prostate adenocarcinoma.